| For: | Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol 2014; 20(40): 14559-14567 [PMID: 25356020 DOI: 10.3748/wjg.v20.i40.14559] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14559.htm |
| Number | Citing Articles |
| 1 |
C. M. Preda, C. P. Popescu, C. Baicus, I. Constantinescu, A. Oproiu, T. Voiosu, M. Diculescu, L. Negreanu, L. Gheorghe, I. Sporea, A. Trifan, E. Ceausu, D. Proca, M. Manuc. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus‐co‐infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. Journal of Viral Hepatitis 2018; 25(7) doi: 10.1111/jvh.12872
|
| 2 |
Harjot K. Bedi, Daljeet Chahal, Christopher F. Lowe, Gordon Ritchie, Trana Hussaini, Vladimir Marquez, Eric M. Yoshida. Occult Hepatitis B Reactivation after Liver Transplant: The Role of a Novel Mutation in the Surface Antigen. Journal of Clinical and Translational Hepatology 2020; 0(000) doi: 10.14218/JCTH.2020.00090
|
| 3 |
Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Andreas Protopapas, Konstantinos Tziomalos. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis. European Journal of Gastroenterology & Hepatology 2018; 30(11) doi: 10.1097/MEG.0000000000001254
|
| 4 |
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Isabella Esposito, Laura Benítez-Gutiérrez, José M Peña, Pablo Barreiro. New hepatitis C therapies for special patient populations. Expert Opinion on Pharmacotherapy 2016; 17(2) doi: 10.1517/14656566.2016.1112790
|
| 5 |
Fei Chen, Jian Zhang, Fengfan Guo, Bo Wen, Shan Luo, Dongping Yuan, Yingbiao Lin, Wensheng Ou, Ping Tang, Guozhi Dai, Fangfang Li, Wenpei Liu, Xiaowang Qu. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population. Journal of Gastroenterology and Hepatology 2017; 32(2) doi: 10.1111/jgh.13460
|
| 6 |
Ruchi Sogarwal, Varada Madge, Pratyush Bishi, Apam Woleng, Rishi Garg. Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in India. Hepatology, Medicine and Policy 2016; 1(1) doi: 10.1186/s41124-016-0010-z
|
| 7 |
Fei Chen, Jian Zhang, Bo Wen, Shan Luo, Yingbiao Lin, Wensheng Ou, Fengfan Guo, Ping Tang, Wenpei Liu, Xiaowang Qu. HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection. Scientific Reports 2016; 6(1) doi: 10.1038/srep39409
|
| 8 |
Carla Osiowy, Fernando Alvarez, Carla S Coffin, Curtis L Cooper, Scott K Fung, Hin Hin Ko, Sébastien Poulin, Jennifer van Gennip. The management of chronic hepatitis B: 2025 Guidelines update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada. Canadian Liver Journal 2025; 8(2) doi: 10.3138/canlivj-2025-0012-e
|
| 9 |
Jamil A. Al‐Mughales. Co‐infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia. Journal of Medical Virology 2016; 88(9) doi: 10.1002/jmv.24503
|
| 10 |
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral. International Journal of Drug Policy 2023; 111 doi: 10.1016/j.drugpo.2015.11.011
|
| 11 |
|
| 12 |
Jiaye Liu, Hui Wu, Hui Chen. Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta‐analysis. Hepatology Research 2018; 48(2) doi: 10.1111/hepr.13008
|
| 13 |
Mengyao Bie, Peiyao Wu, Jieyu Zhou, Yan Li, Lei Zhao. Periodontal health status in cirrhotic patients: a systematic review and meta-analysis. BMC Oral Health 2023; 23(1) doi: 10.1186/s12903-023-03052-5
|
| 14 |
Astrid Marot, Aïmen Belaid, Hans Orlent, Thomas Sersté, Peter Michielsen, Isabelle Colle, Wim Laleman, Chantal de Galocsy, Hendrik Reynaert, François D’Heygere, Christophe Moreno, Christopher Doerig, Jean Henrion, Pierre Deltenre. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clinics and Research in Hepatology and Gastroenterology 2017; 41(6) doi: 10.1016/j.clinre.2017.05.003
|
| 15 |
D. Salmon, M. U. Mondelli, M. Maticic, J. E. Arends. The benefits of hepatitis C virus cure: Every rose has thorns. Journal of Viral Hepatitis 2018; 25(4) doi: 10.1111/jvh.12823
|
| 16 |
Prabha Desikan, Zeba Khan. Prevalence of Hepatitis B and Hepatitis C Virus Co-infection in India: A Systematic Review and Meta-analysis. Indian Journal of Medical Microbiology 2017; 35(3) doi: 10.4103/ijmm.IJMM_17_257
|
| 17 |
Anand V Kulkarni, Nageshwar Reddy Duvvuru. Management of hepatitis B and C in special population. World Journal of Gastroenterology 2021; 27(40): 6861-6873 doi: 10.3748/wjg.v27.i40.6861
|
| 18 |
Yung-Rung Lai, Ya-Lan Chang, Chiu-Hsiang Lee, Tung-Han Tsai, Kuang-Hua Huang, Chien-Ying Lee. Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study. Cancers 2022; 14(3) doi: 10.3390/cancers14030583
|
| 19 |
Jennifer Mbamalu Chinenye, Mercy Ekejindu Ifeoma, Bessie Enweani-Nwokelo Ifeoma, Ikechukwu Okeke Obiefuna, Amaechi Ofodile Chukwudi, Okorafor Kalu Stephen. Frequency of hepatitis C and D virus among chronic hepatitis B virus carriers in a Nigerian tertiary hospital. Journal of Public Health and Epidemiology 2022; 14(1) doi: 10.5897/JPHE2021.1367
|
| 20 |
Quratulain Maqsood, Aleena Sumrin, Maryam Iqbal, Saima Younas, Nazim Hussain, Muhammada Mahnoor, Abdul Wajid. Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives. Antiviral Therapy 2023; 28(4) doi: 10.1177/13596535231189643
|
| 21 |
Cristina Valente, Ruben Carvalho. HBsAg loss after hepatitis B reactivation in a patient with hepatitis C treated with direct-acting antivirals. Revista Portuguesa de Doenças Infecciosas (RPDI) 2026; 20(2) doi: 10.65332/rpdi.v20.150
|
| 22 |
MURAT SAYAN, AYSE ARIKAN, TAMER SANLIDAG. Comparison of Performance Characteristics of DxN VERIS System versus Qiagen PCR for HBV Genotype D and HCV Genotype 1b Quantification. Polish Journal of Microbiology 2019; 68(1) doi: 10.21307/pjm-2019-008
|
| 23 |
Carlos Polanco, Alberto Huberman, Vladimir N. Uversky, Enrique Hernández-Lemus E, Mireya Martínez-Garcia, Martha Rios Castro, Claudia Pimentel Hernández, Thomas Buhse, Gilberto Vargas-Alarcon, Francisco J. Roldan Gomez, Erika Jeannette López Oliva. Bioinformatics Insights on the Physicochemical Properties of Hepatitis Virus Envelope Glycoproteins. Letters in Drug Design & Discovery 2024; 21(14) doi: 10.2174/0115701808264877231014175922
|
| 24 |
Anahita Rahimkhani, Setareh Haghighat, Hassan Noorbazargan, Mehdi Mahdavi. Improvement of hepatitis B vaccine to induce IFN-γ cytokine response: A new formulation. Microbial Pathogenesis 2021; 160 doi: 10.1016/j.micpath.2021.105184
|
| 25 |
Agbogbenkou Tevi Dela Dem Lawson, Maimouna Sidibé, Daouda Thioub, Khadim Mbaye, Sylvie Audrey Diop. Chronic viral hepatitis B: evaluation of the care of patients monitored at the SMIT in Tivaouane, Sénégal. IJID Regions 2025; 16 doi: 10.1016/j.ijregi.2025.100701
|
| 26 |
Jiaye Liu, Shaohui Qiu, Jingjing Lu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, Fuzhen Wang, Peng He, Xin Fang, Zhongyu Hu, Xiaofeng Liang, Aiqiang Xu, Li Zhang. Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China. The Journal of Infectious Diseases 2017; 216(3) doi: 10.1093/infdis/jix295
|
| 27 |
Muhammad Younas Khan Barozai, Muhammad Din. Initial screening of plant most conserved MicroRNAs targeting infectious viruses: HBV and HCV. 2017 14th International Bhurban Conference on Applied Sciences and Technology (IBCAST) 2017; doi: 10.1109/IBCAST.2017.7868055
|
| 28 |
Yin Liu, Lan-Wei Guo, Hui-Fang Xu, Rui-Hua Kang, Li-Yang Zheng, Lu-Yao Zhang, Qiong Chen, Xi-Bin Sun, Shao-Kai Zhang, You-Lin Qiao. Risk of Liver Cirrhosis in HBV/HCV-Infected Individuals with First-Degree Relatives Who Have Liver Cancer: Development and Validation of a Simple Model. Cancer Prevention Research 2022; 15(2) doi: 10.1158/1940-6207.CAPR-21-0220
|
| 29 |
. 2015; doi: 10.70675/a2c2f13cz2abfz4b63za8cfzf47a1dc665ec
|
| 30 |
L. Reinhardt, H. Eiffert, G. Wulf, P. Ströbel, S. C. B. Bremer, A. Amanzada, V. Ellenrieder, A. Neesse. Spontane Remission einer HCV-Infektion nach autologer Stammzelltransplantation bei einem 58-jährigen Patienten. Der Internist 2017; 58(6) doi: 10.1007/s00108-017-0206-3
|
| 31 |
Shaoxia Xu, Qiaofeng Wang, Weihong Zhang, Zhifeng Qiu, Jingtao Cui, Wenjuan Yan, Anping Ni, Julian W. Tang. Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study. PLOS ONE 2015; 10(10) doi: 10.1371/journal.pone.0140854
|
| 32 |
Jacinta A. Holmes, Ming-Lung Yu, Raymond T. Chung. Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals. Expert Opinion on Drug Safety 2017; 16(6) doi: 10.1080/14740338.2017.1325869
|
| 33 |
Ayanaw Abebe, Muluneh Assefa, Debaka Belete, Getachew Ferede. Seroprevalence of Hepatitis B and C Viruses and Their Associated Factors Among Military Personnel at Military Camps in Central Gondar, Ethiopia: A Cross-Sectional Study. Infection and Drug Resistance 2024; doi: 10.2147/IDR.S455562
|
| 34 |
Shilpa Lingala, Marc G. Ghany. Natural History of Hepatitis C. Gastroenterology Clinics of North America 2015; 44(4) doi: 10.1016/j.gtc.2015.07.003
|
| 35 |
Michelle Spaan, Matthew Bruce, Kosh Agarwal, Ivana Carey. The Role of Anti-HBs in Hepatitis B Reactivation during Direct-Acting Antiviral Therapy for Chronic Hepatitis C. Antiviral Therapy 2018; 23(6) doi: 10.3851/IMP3259
|
| 36 |
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, Arun Asif, Chethikkattuveli Salih Abdul Rahim, Anupama Samantasinghar, Fida Hussain Memon, Kyung Hyun Choi. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches. Journal of Medical Virology 2023; 95(4) doi: 10.1002/jmv.28693
|
| 37 |
Luca Foroghi Biland, Ludovica Ferrari, Vincenzo Malagnino, Elisabetta Teti, Carlotta Cerva, Adele Gentile, Marianna Aragri, Romina Salpini, Valentina Svicher, Massimo Andreoni, Loredana Sarmati. Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report. Journal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2232-3
|
| 38 |
Zhi-Wei Chen, Zhao Li, Qiao-He Wang, Xiao-Ling Wu, Hu Li, Hong Ren, Peng Hu. Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western China. Journal of Clinical and Translational Hepatology 2018; 6(X) doi: 10.14218/JCTH.2018.00027
|
| 39 |
Amit Rastogi, Gaurav Agarwal, Sumit Sachan, Aditya Kapoor, Preeti Dabadghao. Challenging Perioperative Management of a MEN2A Syndrome Patient Complicated by Eisenmenger Syndrome. Turkish Journal of Anaesthesiology and Reanimation 2025; 53(2) doi: 10.4274/TJAR.2025.241768
|
| 40 |
Cristina Musolino, Irene Cacciola, Gianluca Tripodi, Daniele Lombardo, Giuseppina Raffa, Angela Alibrandi, Giovanni Squadrito, Giovanni Raimondo, Teresa Pollicino. Behaviour of Occult HBV Infection in HCV-Infected Patients under Treatment with Direct-Acting Antivirals. Antiviral Therapy 2019; 24(3) doi: 10.3851/IMP3288
|
| 41 |
. 2015; doi: 10.70675/1861201cz8d71z4b78za6e9za3249f40396a
|
| 42 |
Shuling Wu, Wei Yi, Yuanjiao Gao, Wen Deng, Xiaoyue Bi, Yanjie Lin, Liu Yang, Yao Lu, Ruyu Liu, Min Chang, Ge Shen, Leiping Hu, Lu Zhang, Minghui Li, Yao Xie. Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.893512
|
| 43 |
Kingsley Andrew Egbe, Anthony C. Ike, Friday Egbe, Nse F. Unam. Hepatitis B and C virus knowledge and infections in Enugu State, Nigeria. Journal of Clinical Virology Plus 2023; 3(4) doi: 10.1016/j.jcvp.2023.100172
|
| 44 |
Marwa Ismail abbas. A Estimation of liver function tests and IL 6 for pregnant women with hepatitis B and C with Baghdad teaching hospital. Journal of Medical and Oral Biosciences 2024; doi: 10.58564/jmob.63
|
| 45 |
Vincent Thibault. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection. The Lancet Gastroenterology & Hepatology 2018; 3(3) doi: 10.1016/S2468-1253(18)30004-9
|
| 46 |
Pascal Mutz, Philippe Metz, Florian A. Lempp, Silke Bender, Bingqian Qu, Katrin Schöneweis, Stefan Seitz, Thomas Tu, Agnese Restuccia, Jamie Frankish, Christopher Dächert, Benjamin Schusser, Ronald Koschny, Georgios Polychronidis, Peter Schemmer, Katrin Hoffmann, Thomas F. Baumert, Marco Binder, Stephan Urban, Ralf Bartenschlager. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Gastroenterology 2018; 154(6) doi: 10.1053/j.gastro.2018.01.044
|
| 47 |
Charles Berabose, Ralf Clemens, Tatiana De Noronha, Sue Ann Costa Clemens. Assessing the Status of and Impediments to Achieving the WHO Goal to Eliminate Viral Hepatitis B by 2030: A Scoping Review. Vaccines 2026; 14(10) doi: 10.3390/vaccines14100846
|
| 48 |
Somayeh Shokri, Shahab Mahmoudvand, Reza Taherkhani, Fatemeh Farshadpour, Farid Azizi Jalalian. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesis. Journal of Cellular Physiology 2019; 234(9) doi: 10.1002/jcp.28249
|
| 49 |
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. International Journal of Drug Policy 2023; 111 doi: 10.1016/j.drugpo.2015.11.010
|
| 50 |
Yong Xie, Tianshi Lyu, Haitao Guan, Li Song, Xiaoqiang Tong, Yinghua Zou, Min Yang, Jian Wang. Burden of liver cancer from 1990 to 2021 and modelled projection to 2040: insights from the global burden of disease study 2021. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1699519
|
| 51 |
Li-Bo Yan, Hui-Ying Rao, Yuan-Ji Ma, Lang Bai, En-Qiang Chen, Ling-Yao Du, Rui-Feng Yang, Lai Wei, Hong Tang. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study. BMJ Open 2016; 6(10) doi: 10.1136/bmjopen-2016-012016
|
| 52 |
Ge Yu, Xiumei Chi, Ruihong Wu, Xiaomei Wang, Xiuzhu Gao, Fei Kong, Xiangwei Feng, Yuanda Gao, Xinxing Huang, Jinglan Jin, Yue Qi, Zhengkun Tu, Bing Sun, Jin Zhong, Yu Pan, Junqi Niu, Yury E Khudyakov. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population. PLOS ONE 2015; 10(9) doi: 10.1371/journal.pone.0139015
|
| 53 |
Lauren Myers, Arnab Mitra, Joseph Ahn. Addressing Hepatitis B in the Context of Hepatitis C. Current Hepatology Reports 2021; 20(4) doi: 10.1007/s11901-021-00578-6
|
| 54 |
Elisabetta Loggi, Stefano Gitto, Silvia Galli, Mario Minichiello, Fabio Conti, Elena Grandini, Alessandra Scuteri, Giovanni Vitale, Roberto Di Donato, Carmela Cursaro, Giuliano Furlini, Pietro Andreone. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice. Journal of Clinical Virology 2017; 93 doi: 10.1016/j.jcv.2017.05.021
|
| 55 |
Marlone Cunha-Silva, Fábio R.T. Marinho, Paulo F. Oliveira, Tirzah M. Lopes, Tiago Sevá-Pereira, Sonia L.S. Lorena, Jazon R.S. Almeida. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors. The Brazilian Journal of Infectious Diseases 2017; 21(4) doi: 10.1016/j.bjid.2017.03.019
|
| 56 |
Aida Lydia, Anindia Larasati, Rino Alvani Gani, Ikhwan Rinaldi. Liver fibrosis of hepatitis C virus infection in routine hemodialysis patients in Indonesia. Medical Journal of Indonesia 2019; 28(4) doi: 10.13181/mji.v28i4.3776
|
| 57 |
Xiao-Xiao Wang, Xiao-Ben Pan, Jin-Chao Han, Xu Cong, Qian Jin, Xiang-Sha Kong, Lai Wei, Bo Feng. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication. Hepatobiliary & Pancreatic Diseases International 2018; 17(3) doi: 10.1016/j.hbpd.2018.03.010
|
| 58 |
Abdul Qadeer Khan, Fakhra Bibi, Saud Fahad Aldosary. Bifurcation analysis and chaos in a discrete Hepatitis B virus model. AIMS Mathematics 2024; 9(7) doi: 10.3934/math.2024956
|
| 59 |
Syeda Najidah Shahni, Sarah Albogami, Iqbal Azmi, Bijay Pattnaik, Rituparna Chaudhuri, Kapil Dev, Jawed Iqbal, Amit Sharma, Tanveer Ahmad, Ashis Basu. Dual Detection of Hepatitis B and C Viruses Using CRISPR‐Cas Systems and Lateral Flow Assay. Journal of Nucleic Acids 2024; 2024(1) doi: 10.1155/2024/8819834
|
| 60 |
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Recommendations for the management of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy 2015; 26(10) doi: 10.1016/j.drugpo.2015.07.005
|
| 61 |
Carla S. Coffin, Scott K. Fung, Fernando Alvarez, Curtis L. Cooper, Karen E. Doucette, Claire Fournier, Erin Kelly, Hin Hin Ko, Mang M Ma, Steven R Martin, Carla Osiowy, Alnoor Ramji, Edward Tam, Jean Pierre Villeneuve. Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Canadian Liver Journal 2018; 1(4) doi: 10.3138/canlivj.2018-0008
|
| 62 |
Elisabetta Degasperi, Massimo Colombo. Hepatitis C: Epidemiology, Prevention and Elimination. 2021; doi: 10.1007/978-3-030-64649-3_7
|
| 63 |
Stefano GITTO, Carmela CURSARO, Alessandra BARTOLI, Marzia MARGOTTI, Pietro ANDREONE. Hepatitis C: clinical management and debated issues. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07208-0
|
| 64 |
Rachael Jacob, Mark Danta. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection. Expert Opinion on Pharmacotherapy 2022; 23(4) doi: 10.1080/14656566.2021.2019708
|
| 65 |
Elaheh Gholami Parizad, Eskandar Gholami Parizad, Afra Khosravi, Mansour Amraei, Azar Valizadeh, Abdoullah Davoudian. Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection. Hepatitis Monthly 2016; 16(5) doi: 10.5812/hepatmon.30385
|
| 66 |
Mohammed Khalid Mahmood, Mohammed Taib Fatih, Handren Ameer Kurda, Nwsiba Khalid Mahmood, Farman Uthman Shareef, Hemin Faraidun, Herve Tassery, Delphine Tardivo, Romain Lan, Zana Fuad Noori, Balen Hamid Qadir, Arman Dlshad Hassan. Role of viruses in periodontitis: An extensive review of herpesviruses, human immunodeficiency virus, coronavirus-19, papillomavirus and hepatitis viruses. World Journal of Virology 2024; 13(4): 99070 doi: 10.5501/wjv.v13.i4.99070
|
| 67 |
Dorota Zarębska-Michaluk, Robert Flisiak, Marta Flisiak-Jackiewicz. Management of hepatitis B and hepatitis C coinfection: an expert review. Expert Review of Anti-infective Therapy 2020; 18(10) doi: 10.1080/14787210.2020.1776112
|
| 68 |
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. Journal of Clinical and Experimental Hepatology 2018; 8(1) doi: 10.1016/j.jceh.2017.12.001
|
| 69 |
Carla Osiowy, Fernando Alvarez, Carla S. Coffin, Curtis L. Cooper, Scott K. Fung, Hin Hin Ko, Sébastien Poulin, Jennifer van Gennip. La prise en charge de l'hépatite B chronique: mise à jour 2025 des lignes directrices de l'Association canadienne pour l'étude du foie et de l'Association pour la microbiologie médicale et l'infectiologie Canada. Canadian Liver Journal 2025; 8(2) doi: 10.3138/canlivj-2025-0012-f
|
| 70 |
Zebin Zhu, Shanzhou Huang, Yixi Zhang, Chengjun Sun, Yunhua Tang, Qiang Zhao, Qi Zhou, Weiqiang Ju, Xiaoshun He. Bioinformatics analysis on multiple Gene Expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapy. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4720-x
|
| 71 |
Jerzy Jaroszewicz, Małgorzata Pawłowska, Krzysztof Simon, Dorota Zarębska-Michaluk, Beata Lorenc, Jakub Klapaczyński, Magdalena Tudrujek-Zdunek, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Katarzyna Paluch, Dorota Dybowska, Iwona Buczyńska, Agnieszka Czauż-Andrzejuk, Hanna Berak, Rafał Krygier, Maciej Piasecki, Beata Dobracka, Jolanta Citko, Anna Piekarska, Łukasz Socha, Zbigniew Deroń, Olga Tronina, Łukasz Laurans, Jolanta Białkowska, Krzysztof Tomasiewicz, Waldemar Halota, Robert Flisiak. Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA. Expert Review of Anti-infective Therapy 2020; 18(10) doi: 10.1080/14787210.2020.1782189
|
| 72 |
Hosee Niyompano, Emmanuel Biracyaza. Prevalence and determinants of hepatitis B surface antigen and anti-HCV seropositivity among patients tested at Mibilizi District Hospital, Rwanda. Discover Public Health 2026; 23(1) doi: 10.1186/s12982-026-01849-7
|
| 73 |
Siyue Zhu, Kibrom Mehari Kahsay, Li Gui. Knowledge, Attitudes and Practices related to standard precautions among nurses: A comparative study. Journal of Clinical Nursing 2019; 28(19-20) doi: 10.1111/jocn.14945
|
| 74 |
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?. World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108
|
| 75 |
Amrita Gaurav, Dhriti Kapur, Neha Verma, Anupama Bahadur, Kavita Khoiwal, Anchal Agarwal, Om Kumari, Jaya Chaturwedi. Do Blood-Borne Viruses Affect the Progression of Labor: A Hospital-Based Pilot Study. Cureus 2021; doi: 10.7759/cureus.15631
|
| 76 |
D. V. Tserashkou, V. M. Mitsura, E. V. Voropaev, O. V. Osipkina. VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE. Hepatology and Gastroenterology 2020; 4(2) doi: 10.25298/2616-5546-2020-4-2-171-176
|
| 77 |
Amin R. Soliman, Rabab M. Ahmed, Mahmoud Soliman, Ahmed Abdallah, Bahaa Zayed. The effect of co-infection with hepatitis B and hepatitis C viruses on the prevalence of proteinuria and loss of renal function: a single-center experience. The Egyptian Journal of Internal Medicine 2018; 30(4) doi: 10.4103/ejim.ejim_51_18
|
| 78 |
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore. Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection. International Journal of Drug Policy 2023; 111 doi: 10.1016/j.drugpo.2015.11.009
|
| 79 |
Qi Wu, Zhubing Li, Qiang Liu. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN. Virology 2018; 520 doi: 10.1016/j.virol.2018.05.011
|
| 80 |
Regiane M. A. Sampaio, Paola Eduarda F. Dantas, Maria Inês C. da Silva, Joseane R. da Silva, Patrícia F. Nunes, Amanda C. Gomes, Luisa C. Martins. Comparison of Patients Monoinfected with Hepatitis C Virus and Coinfected with Hepatitis B/C in the Amazon Region of Brazil. Viruses 2022; 14(5) doi: 10.3390/v14050856
|
| 81 |
Derya BAYIRLI TURAN, Tuba KURUOĞLU, Defne GÜMÜŞ, Fatma KALAYCI, Kıvanç ŞEREFHANOĞLU. Seroprevalence of HBsAg and anti-HCV for patients who admitted to third step hospital: Six-year retrospective data. Ege Tıp Dergisi 2019; 58(2) doi: 10.19161/etd.502958
|
| 82 |
Zeinab Nabil Ahmed Said, Manal Hamdy El-Sayed. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World Journal of Hepatology 2022; 14(7): 1333-1343 doi: 10.4254/wjh.v14.i7.1333
|
| 83 |
V. Calvaruso, D. Ferraro, A. Licata, M. G. Bavetta, S. Petta, F. Bronte, G. Colomba, A. Craxì, V. Di Marco. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct‐acting antivirals. Journal of Viral Hepatitis 2018; 25(1) doi: 10.1111/jvh.12754
|
| 84 |
Bilal Toka, Aydın Şeref Köksal, Ramazan Dertli, Göktuğ Şirin, Sami Fidan, Yakup Ülger, Ferda Harmandar, Abdullah Emre Yıldırım, Ahmet Tarik Eminler, Mehmet Asil, Yusuf Kayar, Murat Bıyık, Sedef Kuran, Mustafa Ihsan Uslan, Sadettin Hülagü. Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C. Digestive Diseases 2022; 40(5) doi: 10.1159/000521298
|
| 85 |
Nathália Alves Araujo de Almeida, Vanessa Salete de Paula. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. Journal of Applied Microbiology 2022; 132(3) doi: 10.1111/jam.15351
|
| 86 |
Giovanni Raimondo, Teresa Pollicino. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; doi: 10.1007/978-3-319-22330-8_13
|
| 87 |
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology 2017; 67(2) doi: 10.1016/j.jhep.2017.03.021
|
| 88 |
Bo Wen, Jian Zhang, Wenpei Liu, Ping Tang, Ting Xie, Liyan Huang, Yabin Hu, Kun Jin, Ping Zhang, Ziyan Liu, Ling Niu, Xiaowang Qu. HBV coinfection with HCV alters circulating Tfh cell distribution and impairs HCV neutralizing antibody responses. Journal of Viral Hepatitis 2019; 26(8) doi: 10.1111/jvh.13106
|
| 89 |
C.E. Burton, K.E. Doucette, C.A. Mabilangan, S.S. Plitt, B.E. Lee, J.K. Preiksaitis. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10‐year review at a single center. Transplant Infectious Disease 2016; 18(4) doi: 10.1111/tid.12558
|
| 90 |
Marianna G. Mavilia, George Y. Wu. HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation. Journal of Clinical and Translational Hepatology 2018; 6(3) doi: 10.14218/JCTH.2018.00016
|
| 91 |
Kevin Lu, Kun-Yuan Chiu. Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection. Transplantation Proceedings 2023; 55(7) doi: 10.1016/j.transproceed.2023.05.017
|